Effects of two treatment techniques over the length and width step people with Parkinson's disease
- Conditions
- Idiopathic Parkinson's disease
- Registration Number
- RBR-6bgqk4
- Lead Sponsor
- niversidade Estadual Paulista
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
will be included Male and female; with a diagnosis of idiopathic Parkinson's disease; classified in stages I to III of Hoehn Yahr; with the realization of independent walking without the use of assistive devices; which do not stage pharmacological adaptation; and can perform assessments and interventions on phase of medications for Parkinson's Disease.
Will be excluded those who experience pain; fracture; or serious injury to soft tissue in the six months previous history to the study and history of cardiovascular or respiratory changes uncontrolled and cognitive changes.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Outcome: Increase in pitch length and gait speed and decrease the variability of step length, step width, step width variability, verified by the gait kinematic analysis in Peak program Motus Motion Measurement System after six weeks of training in addition to the improvement in mobility tests as the Short Physical Performance Battery (SPPB), the Timed up and Go (TUG) and quality of life, assessed by the Parkinson's Disease Questionnary - 39 (PDQ-39); all data will be statistically analyzed and adopted p <0.05 for significant values.
- Secondary Outcome Measures
Name Time Method Increased stride length and velocity of motion and decrease the variability of step length, step width, step width variability, verified by the gait kinematic analysis in Peak program Motus Motion Measurement System every two weeks of training, as well the improvement in mobility tests such as the Short Physical Performance Battery (SPPB), the Timed up and Go (TUG) and quality of life, assessed by the Parkinson's Disease Questionnary - 39 (PDQ-39); all data will be statistically analyzed and adopted p <0.05 for significant values.